Clinical-Stage Platforms
Part of Biotech - Drug Development
 TMO | Thermo Fisher Scientific, Inc. | $212.2b | $579.02 | 0.0% | 34 |
 A | Agilent Technologies Inc. | $39.1b | $141.34 | 0.0% | N/A |
 IQV | IQVIA Holdings Inc. | $38.7b | $232.41 | 0.0% | 23 |
 WAT | Waters Corp | $36.8b | $396.75 | 0.0% | N/A |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $25.3b | $57.27 | 0.0% | 12 |
 WST | West Pharmaceutical Services, Inc. | $24.5b | $350.00 | 0.0% | N/A |
 MEDP | Medpace Holdings, Inc. Common Stock | $16.0b | $585.36 | 0.0% | N/A |
 ASND | Ascendis Pharma A/S Ordinary Share | $16.0b | $254.00 | 0.0% | 217 |
 RVTY | Revvity, Inc. | $12.9b | $113.00 | +0.1% | 250 |
 ICLR | Icon Plc | $12.6b | $161.31 | 0.0% | 1.2K |
 TECH | Bio-Techne Corp. | $11.2b | $71.92 | 0.0% | N/A |
 CRL | Charles River Laboratories International, Inc. | $11.2b | $264.45 | 0.0% | 6 |
 HALO | Halozyme Therapeutics, Inc. | $9.8b | $89.34 | 0.0% | 469 |
 BRKR | Bruker Corporation | $9.6b | $50.83 | 0.0% | 43 |
 AVTR | Avantor, Inc. | $9.3b | $13.22 | 0.0% | N/A |
 QGEN | QIAGEN N.V. | $8.7b | $42.79 | +2.1% | 2.4K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $8.5b | $106.62 | 0.0% | 827 |
 RGEN | Repligen Corp | $8.3b | $159.38 | 0.0% | 244 |
 TWST | Twist Bioscience Corporation Common Stock | $6.3b | $111.56 | 0.0% | 242 |
 CGON | CG Oncology, Inc. Common stock | $6.3b | $74.35 | 0.0% | 564 |
 LGND | Ligand Pharmaceuticals Inc. | $5.8b | $300.89 | 0.0% | 1.1K |
 MANE | Veradermics, Incorporated | $4.3b | $108.65 | 0.0% | 511 |
 CELC | Celcuity Inc. Common Stock | $4.2b | $94.75 | 0.0% | 1 |
 RLAY | Relay Therapeutics, Inc. Common Stock | $4.1b | $19.75 | 0.0% | 35 |
 OGN | Organon & Co. | $3.6b | $13.54 | 0.0% | N/A |
 KOD | Kodiak Sciences Inc Common Stock | $2.6b | $45.52 | 0.0% | 2 |
 TRVI | Trevi Therapeutics, Inc. Common Stock | $2.5b | $19.80 | 0.0% | N/A |
 NRIX | Nurix Therapeutics, Inc. Common stock | $2.4b | $24.93 | 0.0% | N/A |
 DAWN | Day One Biopharmaceuticals, Inc. Common Stock | $2.2b | $21.52 | -0.0% | 3.0M |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $2.2b | $11.85 | 0.0% | 2.7K |
 TYRA | Tyra Biosciences, Inc. Common Stock | $1.9b | $26.47 | 0.0% | 116 |
 FTRE | Fortrea Holdings Inc. Common Stock | $1.8b | $17.68 | 0.0% | N/A |
 GENB | Generate Biomedicines, Inc. Common Stock | $1.8b | $13.96 | 0.0% | 193 |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.8b | $27.50 | 0.0% | N/A |
 ABCL | AbCellera Biologics Inc. Common Shares | $1.7b | $6.58 | 0.0% | 29.1K |
 RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | $1.7b | $3.19 | 0.0% | 30.1K |
 ZYME | Zymeworks Inc. | $1.6b | $23.14 | 0.0% | 2 |
 HROW | Harrow, Inc. Common Stock | $1.4b | $39.88 | 0.0% | 199 |
 GLUE | Monte Rosa Therapeutics, Inc. Common Stock | $1.4b | $15.93 | 0.0% | 607 |
 ALVO | Alvotech Ordinary Shares | $1.4b | $3.81 | 0.0% | 1 |
 ABSI | Absci Corporation Common Stock | $1.3b | $8.40 | 0.0% | 1.7K |
 CERT | Certara, Inc. Common Stock | $1.3b | $8.15 | 0.0% | 12.2K |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.2b | $85.28 | 0.0% | 255 |
 VOR | Vor Biopharma Inc. Common Stock | $1.2b | $23.61 | 0.0% | 218 |
 SDGR | Schrodinger, Inc. Common Stock | $1.1b | $17.75 | 0.0% | 611 |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.1b | $26.25 | 0.0% | 590 |
 OPK | Opko Health Inc. | $1.0b | $1.32 | 0.0% | 5.4K |
 MRVI | Maravai LifeSciences Holdings, Inc. Class A Common Stock | $0.9b | $5.92 | 0.0% | 51 |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $3.37 | 0.0% | 1.3K |
 CADL | Candel Therapeutics, Inc. Common Stock | $0.7b | $10.50 | 0.0% | 11 |